About
About START

Welcome to the START Center for Cancer Research. We are a global leader in cancer research, dedicated to the relentless pursuit of hope for patients and their families.

About

Company

Hope Hub

Leadership

Principal Investigators

Careers

Contact

Our Services

Preclinical

Early Phase
Who We Serve
Who We Serve

We believe that every patient should have the opportunity to access clinical trials, regardless of where they receive their cancer treatment.

Visit The START Hope Hub

We believe that every patient should have the opportunity to access clinical trials, regardless of where they receive their cancer treatment. Designed to help you understand, explore, and enroll in early-phase oncology trials, the START Hope Hub will help guide you through the clinical trial process with confidence.

Explore Hope Hub

Patients & Family

Patients

Explore Clinical Trials

About Clinical Trials

Patient Stories

Referring Physicians

Referring Physicians

Hospitals & Oncology Practices

Hospitals & Oncology Practices

Pharma

Pharma
START Locations
START Research Centers

100,000+ square feet of world-class research facilities

United States Locations

START - San Antonio

START - Midwest

START - Mountain Region

START - Carolinas

START - New York City (Coming Soon)

START - Dallas Fort Worth (Coming Soon)

START - New Jersey (Coming Soon)

START - Los Angeles (Coming Soon)

Europe Locations

START - Madrid - CIOCC

START - Madrid - FJD

START - Barcelona

START - Rioja

START - Lisbon

START - Dublin
Resources
Resources

Stay up to date with everything at START, from blog insights and press and newsroom updates to expert-led webinars and much more.

Resources

Blog

Events

Newsroom

Press

Publications

Webinars

Featured Resources

Newsroom

START and Advarra Unite to Deliver Unmatched Speed, Quality, and Predictability for Early-Phase Oncology Trials

Newsroom

START Launches Hope Hub to Connect Patients, Physicians, and Advocacy Groups to Community-Based Cancer Trials
Hope Hub
Find a Trial

Press

Improving Access to Phase 1 Cell & Gene Therapy Trials in Europe: Perspectives from Dr. Victor Moreno

Leave a Comment / Press / Lauren Panco

Improving Access to Phase 1 Cell & Gene Therapy Trials in Europe: Perspectives from Dr. Victor Moreno Read More »

Dr. Maria de Miguel Analyzes the Future of ADCs in Oncology

Leave a Comment / Press / Lauren Panco

Dr. Maria de Miguel Analyzes the Future of ADCs in Oncology Read More »

Clinical Trials in Community Settings: How Do We Improve Participation?

Leave a Comment / Press / Lauren Panco

Clinical Trials in Community Settings: How Do We Improve Participation? Read More »

START Dublin – the need, the science, and the pure serendipity of it all

Leave a Comment / Press / Lauren Panco

START Dublin – the need, the science, and the pure serendipity of it all Read More »

Dr. Victor Moreno on the Pharmacodynamics of CLN-619 in Advanced Solid Tumors

Leave a Comment / Press / Lauren Panco

Dr. Victor Moreno on the Pharmacodynamics of CLN-619 in Advanced Solid Tumors Read More »

After Wife Dies from Non-Smoking Lung Cancer, Utah Man Urges All to Test for Radon

Leave a Comment / Press / Joel E

After Wife Dies from Non-Smoking Lung Cancer, Utah Man Urges All to Test for Radon Read More »

Advocating for Patient Access with Amita Patnaik, MD, FRCPC

Leave a Comment / Press / Joel E

Advocating for Patient Access with Amita Patnaik, MD, FRCPC Read More »

Circle Pharma Announces First Patients Dosed in Phase 1 Clinical Trial of First-in-Class Oral Cyclin A/B RxL Inhibitor CID-078 for Advanced Solid Tumors

Leave a Comment / Press / Joel E

Circle Pharma Announces First Patients Dosed in Phase 1 Clinical Trial of First-in-Class Oral Cyclin A/B RxL Inhibitor CID-078 for Advanced Solid Tumors Read More »

New Clinical Trial Unit Opens for Irish Cancer Patients

Leave a Comment / Press / Joel E

New Clinical Trial Unit Opens for Irish Cancer Patients Read More »

‘I Had No Lesions On My Skin. It Happens in 5pc of Cases’ – Dublin Woman Reached Stage Four Cancer Before Getting Access to Therapy

Leave a Comment / Press / Joel E

‘I Had No Lesions On My Skin. It Happens in 5pc of Cases’ – Dublin Woman Reached Stage Four Cancer Before Getting Access to Therapy Read More »

Partnership

Quis volutpat scelerisque quis massa in dolor nunc lectus cursus.

Varius nec, elit turpis amet, proin ut sed nec donec auctor dolor arcu, sollicitudin.

Enim nulla elementum sodales dapibus orci, sed quam mattis aliquam dui penatibus aliquet feugiat nisl laoreet placerat pellentesque duis semper pellentesque tempor placerat nam parturient magna volutpat auctor mattis imperdiet sapien ut tortor id amet tempor tortor, augue facilisi mi.

About START

About

Our Services

Who We Serve

Visit The START Hope Hub

Patients & Family

Referring Physicians

Hospitals & Oncology Practices

Pharma

Resources

Resources

Featured Resources

START and Advarra Unite to Deliver Unmatched Speed, Quality, and Predictability for Early-Phase Oncology Trials

START Launches Hope Hub to Connect Patients, Physicians, and Advocacy Groups to Community-Based Cancer Trials

Press

Partnership

Quis volutpat scelerisque quis massa in dolor nunc lectus cursus.